ArticleMedicine2026
Causal relationship between birth weight, uric acid levels, and risk of gout: New insights from a bidirectional two-sample Mendelian randomization study.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bidirectional two-sample Mendelian randomization (MR) was used to evaluate the potential causal effects of birth weight and uric acid levels (the exposures) and the development of gout (the outcome). Genetic instruments derived from aggregated genome-wide association study data of European ancestry were used to investigate the associations between birth weight (261,932 samples, 9,851,867 single-nucleotide polymorphisms [SNPs]), uric acid levels (110,347 samples, 4,865,122 SNPs), and gout (337,159 samples, including 4807 cases and 332,352 controls, 10,894,596 SNPs). The inverse variance weighting method was used for primary causal estimates, and a series of sensitivity analyses were performed to assess the robustness of the results. The study found that birth weight was negatively associated with uric acid levels (odds ratio [OR] = 0.849; 95% confidence interval [CI]: 0.786-0.917; P < .001) and correspondingly had a negative impact on gout risk (OR = 0.997; 95% CI: 0.994-0.9997; P = .032). In reverse MR analyses, genetic liability for gout was strongly associated with lower birth weight (OR = 0.380; 95% CI: 0.222-0.650; P < .001). This indicates that individuals with a higher genetic predisposition to gout have 62% lower odds of having a higher birth weight. However, the reverse MR analysis of birth weight and uric acid levels was influenced by horizontal pleiotropy and could not provide additional scientific insights. Genetically predicted higher birth weight demonstrated a protective causal effect on serum urate levels. Specifically, each 1-standard deviation increase in birth weight was associated with a 15.1% reduction in the odds of hyperuricemia (OR = 0.849; 95% CI: 0.786-0.917; P < .001). This causal estimate was robust across sensitivity analyses, including the weighted median and MR-Egger methods, with no evidence of directional pleiotropy (Egger intercept P > .05). Leave-one-out analysis confirmed that the results were not driven by any single influential genetic variant.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.